Mironid
is a Scotland-based biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of autosomal dominant polycystic kidney disease... Read moreMironid
is a Scotland-based biopharmaceutical company that researches and develops small-molecule therapeutics for the treatment of autosomal dominant polycystic kidney disease... Read more
News
May 28, 2024
Life Care News
Mironid: Mironid Presents Translational Data in Oral Presentation at
Oct 24, 2023
Vietnam Insider
Mironid: Mironid appoints Dr Catherine Kelleher as Chief Medical Officer
Jul 01, 2019
BioPortfolio
Mironid: New drug compound could tackle hereditary kidney disease
Aug 01, 2018
BioPortfolio
Mironid: Mironid Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23042018 Prices from USD $250
Oct 16, 2017
BioPortfolio
Mironid Limited: Mironid Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12102017 Prices from USD $250
May 30, 2017
BioPortfolio
Mironid Limited: Mironid Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Updated 10052017 Prices from USD $250
Mar 07, 2017
BioPortfolio
Mironid Limited: Mironid Ltd Pharmaceuticals Healthcare Deals and Alliances Profile Updated 17022017 Prices from USD $250
Dec 12, 2016
BioPortfolio
Mironid Limited: Mironid and University of Sheffield Collaborate on Kidney Disease Drug Discovery
Jul 01, 2016
Equities
Mironid Limited: Mironid Announces Closing of £4.3 Million $6.2 Million Series a Financing
Jun 22, 2016
BioPortfolio
Mironid Limited: Mironid Announces Closing of £4.3 million $6.2 million Series A Financing.
Mironid Competitors
1
2
3
4
5
6
7
8
9
10